Free Trial
→ Missed Nvidia? Watch this ASAP (From Brownstone Research) (Ad)

20 Stocks Wall Street Analysts Love the Most - 18 of 20

Slide 18
Back to 17
Continue to 19
 
Back to 17
Continue to 19
 

ADMA Biologics (NASDAQ:ADMA)

Consensus Rating
Buy
Rating Score
3.3
Ratings Breakdown
4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$21.25 (2.7% Downside)

About ADMA Biologics

ADMA Biologics logoADMA Biologics, Inc, a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/8/2024HC WainwrightBoost Price TargetBuy ➝ Buy$18.00 ➝ $26.00
11/8/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$18.00 ➝ $25.00
10/14/2024HC WainwrightReiterated RatingBuy ➝ Buy$18.00 ➝ $18.00
9/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$20.00 ➝ $20.00
8/12/2024HC WainwrightBoost Price TargetBuy ➝ Buy$10.00 ➝ $18.00
8/9/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$15.00 ➝ $20.00
7/9/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$10.00 ➝ $15.00
6/20/2024MizuhoBoost Price TargetBuy ➝ Buy$12.00 ➝ $14.00
5/10/2024Raymond JamesBoost Price TargetStrong-Buy ➝ Strong-Buy$8.00 ➝ $10.00
5/10/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$8.00 ➝ $10.00
Slide 18
Back to 17
Continue to 19
 

Election warning coming true… (Ad)

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

More From MarketBeat
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
7 Artificial Intelligence Stocks That Are Still Long-Term Winners
It's hard to believe that two years ago, many of us had never heard of ChatGPT. But for the last 18 months, in...
MarketBeat
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...
Weiss Ratings | Sponsored
7 Best Stocks Under $5 to Buy Now
What is it about stocks under $5 that fascinates investors? Part of it, for sure, is the allure of finding the...
MarketBeat
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
7 Infrastructure Stocks to Buy Like There's No Tomorrow
Members of Congress agree on very few things. But in the last four years, there has been bipartisan support fo...
MarketBeat